How PE Buyers Evaluate Healthcare Practice Acquisitions
Private equity groups use specific criteria when evaluating med spa and clinic acquisitions. Understanding what they look for helps you build a more valuable practice — whether you plan to sell or not.
How PE Buyers Evaluate Healthcare Practice Acquisitions
Private equity groups have been among the most active acquirers of medical spas, weight loss clinics, and aesthetic medicine practices over the past several years. Understanding how they evaluate acquisition targets is valuable whether you are planning to sell in the near term or simply want to build a more valuable practice.
Our team has direct relationships with PE groups actively acquiring in this space and has MBA and JD credentials. Here is what we have seen in the due diligence process.
The PE Investment Thesis for Medical Aesthetics
Before diving into evaluation criteria, it helps to understand why PE is interested in this space:
Fragmentation: The medical aesthetics market is highly fragmented. PE firms see consolidation opportunity — buying multiple practices, standardizing operations, and creating regional or national platforms that command higher exit multiples.
Recurring revenue: GLP-1 programs, membership models, and subscription-based services generate predictable recurring revenue that PE buyers value highly.
Demographic tailwinds: Demand for aesthetic and wellness services continues to grow. The patient population is expanding, not contracting.
Telehealth scalability: Practices with telehealth components can scale patient volume without proportional increases in physical infrastructure — a key driver of margin expansion.
Multiple arbitrage: PE firms buy individual practices at lower multiples and sell the consolidated platform at a higher multiple. The math works as long as the underlying businesses are solid.
The Key Evaluation Criteria
1. EBITDA and Margin Profile
EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is the primary financial metric PE buyers use to value practices. They will normalize your EBITDA by:
- Adding back owner compensation above market rate
- Adding back one-time expenses
- Adjusting for any non-recurring revenue
The resulting "adjusted EBITDA" is what they apply a multiple to. Typical multiples in this space range from 4–8x adjusted EBITDA, with higher multiples for practices with:
- Strong recurring revenue
- Multiple locations
- Telehealth capability
- Clean compliance records
- Scalable operations
2. Revenue Quality and Recurring Revenue
Not all revenue is equal in PE's eyes. They distinguish between:
Recurring revenue (highest value): Monthly membership fees, subscription GLP-1 programs, ongoing treatment protocols
Repeat revenue (high value): Patients who return regularly but are not on formal subscriptions
One-time revenue (lower value): Single-visit patients, one-time procedures
Practices with a high proportion of recurring revenue command significantly higher multiples.
3. Patient Base Metrics
PE buyers analyze your patient base in detail:
- Active patient count: Patients seen in the last 12 months
- Patient retention rate: What percentage of patients return?
- Average revenue per patient: How much does each patient spend annually?
- Patient lifetime value: How long do patients stay with your practice?
- New patient acquisition rate: How efficiently are you growing?
The ~$2,500 per patient valuation we have seen in the market is based on practices with strong retention metrics and documented active patient relationships.
4. Compliance Record
PE buyers conduct thorough compliance due diligence. They will review:
- State medical board records for any complaints or disciplinary actions
- DEA records (if applicable)
- FDA inspection history (for practices with compounding relationships)
- Employment records and any HR issues
- Malpractice history
- Litigation history
A single significant compliance issue can kill a deal or dramatically reduce the price. Clean compliance records are table stakes.
5. Management Team and Key Person Risk
PE buyers are wary of practices where the value is entirely dependent on the founder. They will assess:
- Whether the practice can operate without the founder
- Whether key staff will stay post-acquisition
- Whether patient relationships are with the practice or with individual providers
- Whether protocols are documented and transferable
Practices with documented protocols, trained staff, and systems that do not depend on the founder command higher multiples.
6. Technology and Systems
Modern PE buyers look for practices with:
- Electronic health records (EHR) systems
- Practice management software
- Patient communication systems
- Financial reporting systems
Practices still running on paper or spreadsheets are harder to integrate into a PE platform.
7. Real Estate and Lease Terms
PE buyers will review your lease terms carefully. Favorable lease terms (long remaining term, reasonable rent, renewal options) are an asset. Unfavorable terms (short remaining term, above-market rent, no renewal options) can be a liability.
The Due Diligence Process
Once a PE buyer issues an LOI, due diligence typically takes 60–90 days and covers:
Financial due diligence: 3 years of financial statements, tax returns, accounts receivable aging, revenue by service line
Legal due diligence: Corporate documents, contracts, licenses, litigation history, employment agreements
Operational due diligence: Site visits, staff interviews, protocol review, technology assessment
Compliance due diligence: Licensing records, board records, DEA records, supply chain documentation
Clinical due diligence: Quality metrics, adverse event history, clinical protocols
How We Support the Process
Our team's MBA and JD credentials mean we can support the entire M&A process — from initial valuation through due diligence and close. We have direct relationships with PE buyers and can make warm introductions to qualified acquirers.
This content is for informational purposes only and does not constitute legal or financial advice.
Explore Topics
Written by
MedClinic Partners Editorial Team
B2B Medical Supply & Compounding Experts
The MedClinic Partners editorial team is composed of licensed medical operators, compounding compliance specialists, and mass-tort attorneys with direct experience running GLP-1 and peptide programs across all 50 states. Every article is reviewed for clinical accuracy, regulatory compliance, and practical applicability before publication.
Editorial standards: All content on medclinicpartners.com is reviewed by licensed medical operators and compounding compliance specialists before publication. Articles are updated when regulatory guidance changes. This content is for licensed healthcare providers only and does not constitute medical advice.
